{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:19:28Z","timestamp":1787163568206,"version":"build-2736575974"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"JPB Foundation, Andrew & Peggy Cherng, Samuel Yin, Carol Ludwig, David & Roger Wu"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Prophylactic vaccines for SARS-CoV-2 have lowered the incidence of severe COVID-19, but emergence of viral variants that are antigenically distinct from the vaccine strains are of concern and additional, broadly acting preventive approaches are desirable. Here, we report on a glycolipid termed 7DW8-5 that exploits the host innate immune system to enable rapid control of viral infections in vivo. This glycolipid binds to CD1d on antigen-presenting cells and thereby stimulates NKT cells to release a cascade of cytokines and chemokines. The intranasal administration of 7DW8-5 prior to virus exposure significantly blocked infection by three different authentic variants of SARS-CoV-2, as well as by respiratory syncytial virus and influenza virus, in mice or hamsters. We also found that this protective antiviral effect is both host-directed and mechanism-specific, requiring both the CD1d molecule and interferon-\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\gamma$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mi>\u03b3<\/mml:mi>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    . A chemical compound like 7DW8-5 that is easy to administer and cheap to manufacture may be useful not only in slowing the spread of COVID-19 but also in responding to future pandemics long before vaccines or drugs are developed.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-39738-1","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T19:04:01Z","timestamp":1688497441000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["An immunostimulatory glycolipid that blocks SARS-CoV-2, RSV, and influenza infections in vivo"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-277X","authenticated-orcid":false,"given":"Moriya","family":"Tsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5994-3957","authenticated-orcid":false,"given":"Manoj S.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3041-1305","authenticated-orcid":false,"given":"Kazuya","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlu","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamarand L.","family":"Darling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuljeet","family":"Seehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngmin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gata Lopes","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovane Marques","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corredor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana Grazziela Alves","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munemasa","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4700-8224","authenticated-orcid":false,"given":"Adrianus C. M.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6270-1644","authenticated-orcid":false,"given":"Yaoxing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-149X","authenticated-orcid":false,"given":"David D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"39738_CR1","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N. Engl. J. Med. 386, 1397\u20131408 (2022).","journal-title":"N. Engl. J. Med."},{"key":"39738_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2021","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509\u2013520 (2021).","journal-title":"N. Engl. J. Med."},{"key":"39738_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","volume":"21","author":"PC Taylor","year":"2021","unstructured":"Taylor, P. C. et al. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat. Rev. Immunol. 21, 382\u2013393 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"39738_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1126\/science.abn1900","volume":"375","author":"AM Edwards","year":"2022","unstructured":"Edwards, A. M., Baric, R. S., Saphire, E. O. & Ulmer, J. B. Stopping pandemics before they start: Lessons learned from SARS-CoV-2. Science 375, 1133\u20131139 (2022).","journal-title":"Science"},{"key":"39738_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"39738_CR6","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"39738_CR7","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","volume":"604","author":"S Iketani","year":"2022","unstructured":"Iketani, S. et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature 604, 553\u2013556 (2022).","journal-title":"Nature"},{"key":"39738_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"39738_CR9","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1165\/rcmb.2020-0241OC","volume":"63","author":"S Wali","year":"2020","unstructured":"Wali, S. et al. Immune modulation to improve survival of viral pneumonia in mice. Am. J. Respir. Cell Mol. Biol. 63, 758\u2013766 (2020).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"39738_CR10","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","volume":"23","author":"M Kronenberg","year":"2005","unstructured":"Kronenberg, M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877\u2013900 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"39738_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.15.1.535","volume":"15","author":"A Bendelac","year":"1997","unstructured":"Bendelac, A., Rivera, M. N., Park, S. H. & Roark, J. H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15, 535\u2013562 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"39738_CR12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni.3298","volume":"16","author":"DI Godfrey","year":"2015","unstructured":"Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J. & Moody, D. B. The burgeoning family of unconventional T cells. Nat. Immunol. 16, 1114\u20131123 (2015).","journal-title":"Nat. Immunol."},{"key":"39738_CR13","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1182\/blood-2007-05-092866","volume":"111","author":"GJ Renukaradhya","year":"2008","unstructured":"Renukaradhya, G. J. et al. Type I NKT cells protect (and type II NKT cells suppress) the host\u2019s innate antitumor immune response to a B-cell lymphoma. Blood 111, 5637\u20135645 (2008).","journal-title":"Blood"},{"key":"39738_CR14","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1084\/jem.20031192","volume":"198","author":"J Schmieg","year":"2003","unstructured":"Schmieg, J., Yang, G., Franck, R. W. & Tsuji, M. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J. Exp. Med. 198, 1631\u20131641 (2003).","journal-title":"J. Exp. Med."},{"key":"39738_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/156652409787314534","volume":"9","author":"L Wu","year":"2009","unstructured":"Wu, L. & Van Kaer, L. Natural killer T cells and autoimmune disease. Curr. Mol. Med. 9, 4\u201314 (2009).","journal-title":"Curr. Mol. Med."},{"key":"39738_CR16","doi-asserted-by":"publisher","first-page":"8461","DOI":"10.1073\/pnas.97.15.8461","volume":"97","author":"G Gonzalez-Aseguinolaza","year":"2000","unstructured":"Gonzalez-Aseguinolaza, G. et al. alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc. Natl Acad. Sci. USA 97, 8461\u20138466 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR17","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20102555","volume":"208","author":"M Brigl","year":"2011","unstructured":"Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163\u20131177 (2011).","journal-title":"J. Exp. Med."},{"key":"39738_CR18","doi-asserted-by":"publisher","first-page":"19863","DOI":"10.1073\/pnas.0810519105","volume":"105","author":"E Tupin","year":"2008","unstructured":"Tupin, E. et al. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 105, 19863\u201319868 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR19","doi-asserted-by":"publisher","first-page":"e1000239","DOI":"10.1371\/journal.ppat.1000239","volume":"4","author":"I Sada-Ovalle","year":"2008","unstructured":"Sada-Ovalle, I., Chiba, A., Gonzales, A., Brenner, M. B. & Behar, S. M. Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathog. 4, e1000239 (2008).","journal-title":"PLoS Pathog."},{"key":"39738_CR20","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","volume":"188","author":"L Brossay","year":"1998","unstructured":"Brossay, L. et al. CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188, 1521\u20131528 (1998).","journal-title":"J. Exp. Med."},{"key":"39738_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02911-y","volume":"9","author":"K Oleinika","year":"2018","unstructured":"Oleinika, K. et al. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells. Nat. Commun. 9, 684 (2018).","journal-title":"Nat. Commun."},{"key":"39738_CR22","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1002\/eji.200738017","volume":"38","author":"LP Ho","year":"2008","unstructured":"Ho, L. P. et al. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur. J. Immunol. 38, 1913\u20131922 (2008).","journal-title":"Eur. J. Immunol."},{"key":"39738_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1517\/14712590802653601","volume":"13","author":"MS Tessmer","year":"2009","unstructured":"Tessmer, M. S., Fatima, A., Paget, C., Trottein, F. & Brossay, L. NKT cell immune responses to viral infection. Expert. Opin. Ther. Targets 13, 153\u2013162 (2009).","journal-title":"Expert. Opin. Ther. Targets"},{"key":"39738_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.virol.2010.08.030","volume":"407","author":"H Ishikawa","year":"2010","unstructured":"Ishikawa, H. et al. IFN-gamma production downstream of NKT cell activation in mice infected with influenza virus enhances the cytolytic activities of both NK cells and viral antigen-specific CD8+ T cells. Virology 407, 325\u2013332 (2010).","journal-title":"Virology"},{"key":"39738_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-017-0327-8","volume":"14","author":"E Littwitz-Salomon","year":"2017","unstructured":"Littwitz-Salomon, E., Schimmer, S. & Dittmer, U. Natural killer T cells contribute to the control of acute retroviral infection. Retrovirology 14, 5 (2017).","journal-title":"Retrovirology"},{"key":"39738_CR26","doi-asserted-by":"publisher","first-page":"eabj8760","DOI":"10.1126\/sciimmunol.abj8760","volume":"7","author":"G Cui","year":"2022","unstructured":"Cui, G. et al. A circulating subset of iNKT cells mediates antitumor and antiviral immunity. Sci. Immunol. 7, eabj8760 (2022).","journal-title":"Sci. Immunol."},{"key":"39738_CR27","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/eji.201445209","volume":"45","author":"P Riese","year":"2015","unstructured":"Riese, P. et al. Activated NKT cells imprint NK-cell differentiation, functionality and education. Eur. J. Immunol. 45, 1794\u20131807 (2015).","journal-title":"Eur. J. Immunol."},{"key":"39738_CR28","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3389\/fimmu.2019.01849","volume":"10","author":"S Trittel","year":"2019","unstructured":"Trittel, S. et al. Invariant NKT cell-mediated modulation of ILC1s as a tool for mucosal immune intervention. Front Immunol 10, 1849 (2019).","journal-title":"Front Immunol"},{"key":"39738_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cell.2017.11.036","volume":"172","author":"M Gaya","year":"2018","unstructured":"Gaya, M. et al. Initiation of antiviral B cell immunity relies on innate signals from spatially positioned NKT cells. Cell 172, 517\u2013533.e520 (2018).","journal-title":"Cell"},{"key":"39738_CR30","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1128\/JVI.76.9.4294-4303.2002","volume":"76","author":"TR Johnson","year":"2002","unstructured":"Johnson, T. R., Hong, S., Van Kaer, L., Koezuka, Y. & Graham, B. S. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294\u20134303 (2002).","journal-title":"J. Virol."},{"key":"39738_CR31","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","volume":"278","author":"T Kawano","year":"1997","unstructured":"Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626\u20131629 (1997).","journal-title":"Science"},{"key":"39738_CR32","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1073\/pnas.0407488102","volume":"102","author":"KO Yu","year":"2005","unstructured":"Yu, K. O. et al. Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. Proc. Natl Acad. Sci. USA 102, 3383\u20133388 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR33","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.chembiol.2011.10.015","volume":"18","author":"AJ Tyznik","year":"2011","unstructured":"Tyznik, A. J. et al. Glycolipids that elicit IFN-gamma-biased responses from natural killer T cells. Chem. Biol. 18, 1620\u20131630 (2011).","journal-title":"Chem. Biol."},{"key":"39738_CR34","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1016\/j.bmcl.2012.05.009","volume":"22","author":"PJ Jervis","year":"2012","unstructured":"Jervis, P. J. et al. New CD1d agonists: synthesis and biological activity of 6\u201d-triazole-substituted alpha-galactosyl ceramides. Bioorg. Med. Chem. Lett. 22, 4348\u20134352 (2012).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"39738_CR35","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1021\/acs.bioconjchem.8b00484","volume":"29","author":"N Veerapen","year":"2018","unstructured":"Veerapen, N. et al. Photoactivable glycolipid antigens generate stable conjugates with CD1d for invariant natural killer T cell activation. Bioconjug. Chem. 29, 3161\u20133173 (2018).","journal-title":"Bioconjug. Chem."},{"key":"39738_CR36","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/cbic.201200004","volume":"13","author":"MH Hsieh","year":"2012","unstructured":"Hsieh, M. H. et al. Synthesis and evaluation of acyl-chain- and galactose-6\u201d-modified analogues of alpha-GalCer for NKT cell activation. Chembiochem 13, 1689\u20131697 (2012).","journal-title":"Chembiochem"},{"key":"39738_CR37","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1016\/j.bmc.2015.04.068","volume":"23","author":"J Guillaume","year":"2015","unstructured":"Guillaume, J. et al. Synthesis of C-5\u201d and C-6\u201d-modified alpha-GalCer analogues as iNKT-cell agonists. Bioorg. Med. Chem. 23, 3175\u20133182 (2015).","journal-title":"Bioorg. Med. Chem."},{"key":"39738_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04461-7","volume":"7","author":"J Guillaume","year":"2017","unstructured":"Guillaume, J. et al. Galactosylsphingamides: new alpha-GalCer analogues to probe the F\u2019-pocket of CD1d. Sci. Rep. 7, 4276 (2017).","journal-title":"Sci. Rep."},{"key":"39738_CR39","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/eji.201546114","volume":"46","author":"JP Jukes","year":"2016","unstructured":"Jukes, J. P. et al. Non-glycosidic compounds can stimulate both human and mouse iNKT cells. Eur. J. Immunol. 46, 1224\u20131234 (2016).","journal-title":"Eur. J. Immunol."},{"key":"39738_CR40","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1021\/acsmedchemlett.7b00107","volume":"8","author":"J Janssens","year":"2017","unstructured":"Janssens, J. et al. Efficient divergent synthesis of new immunostimulant 4\u201d-modified alpha-galactosylceramide analogues. ACS Med. Chem. Lett. 8, 642\u2013647 (2017).","journal-title":"ACS Med. Chem. Lett."},{"key":"39738_CR41","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.chembiol.2018.06.008","volume":"25","author":"D Chennamadhavuni","year":"2018","unstructured":"Chennamadhavuni, D. et al. Dual modifications of alpha-galactosylceramide synergize to promote activation of human invariant natural killer T cells and stimulate anti-tumor immunity. Cell Chem. Biol. 25, 925 (2018).","journal-title":"Cell Chem. Biol."},{"key":"39738_CR42","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1002\/chem.201905279","volume":"26","author":"N Hartrampf","year":"2020","unstructured":"Hartrampf, N. et al. Optical control of cytokine production using photoswitchable galactosylceramides. Chemistry 26, 4476\u20134479 (2020).","journal-title":"Chemistry"},{"key":"39738_CR43","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1021\/acschembio.0c00707","volume":"15","author":"NA Saavedra-Avila","year":"2020","unstructured":"Saavedra-Avila, N. A. et al. Amide-linked C4\u201d-saccharide modification of KRN7000 provides potent stimulation of human invariant NKT cells and anti-tumor immunity in a humanized mouse model. ACS Chem. Biol. 15, 3176\u20133186 (2020).","journal-title":"ACS Chem. Biol."},{"key":"39738_CR44","doi-asserted-by":"publisher","first-page":"13010","DOI":"10.1073\/pnas.1006662107","volume":"107","author":"X Li","year":"2010","unstructured":"Li, X. et al. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant. Proc. Natl Acad. Sci. USA 107, 13010\u201313015 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR45","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.192.7.921","volume":"192","author":"K Kakimi","year":"2000","unstructured":"Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921\u2013930 (2000).","journal-title":"J. Exp. Med."},{"key":"39738_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1084\/jem.20030324","volume":"198","author":"S Fujii","year":"2003","unstructured":"Fujii, S., Shimizu, K., Smith, C., Bonifaz, L. & Steinman, R. M. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198, 267\u2013279 (2003).","journal-title":"J. Exp. Med."},{"key":"39738_CR47","doi-asserted-by":"publisher","first-page":"5140","DOI":"10.4049\/jimmunol.171.10.5140","volume":"171","author":"IF Hermans","year":"2003","unstructured":"Hermans, I. F. et al. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171, 5140\u20135147 (2003).","journal-title":"J. Immunol."},{"key":"39738_CR48","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.4049\/jimmunol.1002348","volume":"186","author":"C Paget","year":"2011","unstructured":"Paget, C. et al. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J. Immunol. 186, 5590\u20135602 (2011).","journal-title":"J. Immunol."},{"key":"39738_CR49","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1073\/pnas.0813309106","volume":"106","author":"C Guillonneau","year":"2009","unstructured":"Guillonneau, C. et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl Acad. Sci. USA 106, 3330\u20133335 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR50","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5217\/ir.2019.00132","volume":"18","author":"C Lee","year":"2020","unstructured":"Lee, C., Hong, S. N. & Kim, Y. H. A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells. Intest. Res. 18, 402\u2013411 (2020).","journal-title":"Intest. Res."},{"key":"39738_CR51","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","volume":"183","author":"SR Leist","year":"2020","unstructured":"Leist, S. R. et al. A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice. Cell 183, 1070\u20131085.e1012 (2020).","journal-title":"Cell"},{"key":"39738_CR52","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1172\/JCI24762","volume":"115","author":"VV Parekh","year":"2005","unstructured":"Parekh, V. V. et al. Glycolipid antigen induces long-term natural killer T cell anergy in mice. J. Clin. Invest. 115, 2572\u20132583 (2005).","journal-title":"J. Clin. Invest."},{"key":"39738_CR53","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ni827","volume":"3","author":"S Fujii","year":"2002","unstructured":"Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R. M. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. Nat. Immunol. 3, 867\u2013874 (2002).","journal-title":"Nat. Immunol."},{"key":"39738_CR54","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1002\/eji.201041359","volume":"41","author":"AN Courtney","year":"2011","unstructured":"Courtney, A. N. et al. Intranasal but not intravenous delivery of the adjuvant alpha-galactosylceramide permits repeated stimulation of natural killer T cells in the lung. Eur. J. Immunol. 41, 3312\u20133322 (2011).","journal-title":"Eur. J. Immunol."},{"key":"39738_CR55","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/s41591-019-0635-8","volume":"25","author":"M Mori","year":"2019","unstructured":"Mori, M. et al. Generation of functional lungs via conditional blastocyst complementation using pluripotent stem cells. Nat. Med. 25, 1691\u20131698 (2019).","journal-title":"Nat. Med."},{"key":"39738_CR56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 603, 687\u2013692 (2022).","journal-title":"Nature"},{"key":"39738_CR57","doi-asserted-by":"publisher","first-page":"eabm3302","DOI":"10.1126\/scitranslmed.abm3302","volume":"14","author":"B Ying","year":"2022","unstructured":"Ying, B. et al. Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains. Sci. Transl. Med. 14, eabm3302 (2022).","journal-title":"Sci. Transl. Med."},{"key":"39738_CR58","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41590-020-0778-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat. Immunol. 21, 1327\u20131335 (2020).","journal-title":"Nat. Immunol."},{"key":"39738_CR59","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1128\/JVI.01693-10","volume":"85","author":"KL Stokes","year":"2011","unstructured":"Stokes, K. L. et al. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB\/c mice. J. Virol. 85, 5782\u20135793 (2011).","journal-title":"J. Virol."},{"key":"39738_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1465-9921-10-112","volume":"10","author":"FR Toapanta","year":"2009","unstructured":"Toapanta, F. R. & Ross, T. M. Impaired immune responses in the lungs of aged mice following influenza infection. Respir. Res. 10, 112 (2009).","journal-title":"Respir. Res."},{"key":"39738_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1369-5274(00)00199-5","volume":"4","author":"R Shtrichman","year":"2001","unstructured":"Shtrichman, R. & Samuel, C. E. The role of gamma interferon in antimicrobial immunity. Curr. Opin. Microbiol. 4, 251\u2013259 (2001).","journal-title":"Curr. Opin. Microbiol."},{"key":"39738_CR62","doi-asserted-by":"publisher","first-page":"110799","DOI":"10.1016\/j.celrep.2022.110799","volume":"39","author":"Z Chong","year":"2022","unstructured":"Chong, Z. et al. Nasally delivered interferon-lambda protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep. 39, 110799 (2022).","journal-title":"Cell Rep."},{"key":"39738_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13116","volume":"7","author":"H Georgiev","year":"2016","unstructured":"Georgiev, H., Ravens, I., Benarafa, C., Forster, R. & Bernhardt, G. Distinct gene expression patterns correlate with developmental and functional traits of iNKT subsets. Nat. Commun. 7, 13116 (2016).","journal-title":"Nat. Commun."},{"key":"39738_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jim.2009.04.002","volume":"345","author":"T Shiratsuchi","year":"2009","unstructured":"Shiratsuchi, T., Schneck, J., Kawamura, A. & Tsuji, M. Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells. J. Immunol. Methods 345, 49\u201359 (2009).","journal-title":"J. Immunol. Methods"},{"key":"39738_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie, X. et al. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe 27, 841\u2013848.e843 (2020).","journal-title":"Cell Host Microbe"},{"key":"39738_CR66","doi-asserted-by":"publisher","first-page":"e3001143","DOI":"10.1371\/journal.pbio.3001143","volume":"19","author":"NG Ravindra","year":"2021","unstructured":"Ravindra, N. G. et al. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol. 19, e3001143 (2021).","journal-title":"PLoS Biol."},{"key":"39738_CR67","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.chom.2021.02.019","volume":"29","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host Microbe 29, 551\u2013563.e555 (2021).","journal-title":"Cell Host Microbe"},{"key":"39738_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02647.x","volume":"122","author":"CJ Montoya","year":"2007","unstructured":"Montoya, C. J. et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 122, 1\u201314 (2007).","journal-title":"Immunology"},{"key":"39738_CR69","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2015.06.025","volume":"43","author":"YJ Lee","year":"2015","unstructured":"Lee, Y. J. et al. Tissue-specific distribution of iNKT cells impacts their cytokine response. Immunity 43, 566\u2013578 (2015).","journal-title":"Immunity"},{"key":"39738_CR70","first-page":"3702","volume":"8","author":"G Giaccone","year":"2002","unstructured":"Giaccone, G. et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8, 3702\u20133709 (2002).","journal-title":"Clin. Cancer Res."},{"key":"39738_CR71","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1182\/blood-2003-04-1155","volume":"103","author":"M Nieda","year":"2004","unstructured":"Nieda, M. et al. Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383\u2013389 (2004).","journal-title":"Blood"},{"key":"39738_CR72","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jhep.2007.04.018","volume":"47","author":"BJ Veldt","year":"2007","unstructured":"Veldt, B. J. et al. Randomized placebo controlled phase I\/II trial of alpha-galactosylceramide for the treatment of chronic hepatitis C. J. Hepatol. 47, 356\u2013365 (2007).","journal-title":"J. Hepatol."},{"key":"39738_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3851\/IMP1295","volume":"14","author":"AM Woltman","year":"2009","unstructured":"Woltman, A. M. et al. Alpha-galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I\/II trial. Antivir. Ther. 14, 809\u2013818 (2009).","journal-title":"Antivir. Ther."},{"key":"39738_CR74","doi-asserted-by":"publisher","first-page":"e78407","DOI":"10.1371\/journal.pone.0078407","volume":"8","author":"NN Padte","year":"2013","unstructured":"Padte, N. N. et al. A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates. PLoS ONE 8, e78407 (2013).","journal-title":"PLoS ONE"},{"key":"39738_CR75","doi-asserted-by":"crossref","unstructured":"Markov, P.V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361\u2013379 (2023).","DOI":"10.1038\/s41579-023-00878-2"},{"key":"39738_CR76","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/d41586-022-00428-5","volume":"603","author":"A Dance","year":"2022","unstructured":"Dance, A. Omicron\u2019s lasting mysteries: four questions scientists are racing to answer. Nature 603, 22\u201324 (2022).","journal-title":"Nature"},{"key":"39738_CR77","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","volume":"593","author":"P Wang","year":"2021","unstructured":"Wang, P. et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593, 130\u2013135 (2021).","journal-title":"Nature"},{"key":"39738_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2144\/000112531","volume":"43","author":"MB Antunes","year":"2007","unstructured":"Antunes, M. B. et al. Murine nasal septa for respiratory epithelial air-liquid interface cultures. BioTechniques 43, 195\u2013204 (2007).","journal-title":"BioTechniques"},{"key":"39738_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virol.2020.05.015","volume":"548","author":"JB Case","year":"2020","unstructured":"Case, J. B., Bailey, A. L., Kim, A. S., Chen, R. E. & Diamond, M. S. Growth, detection, quantification, and inactivation of SARS-CoV-2. Virology 548, 39\u201348 (2020).","journal-title":"Virology"},{"key":"39738_CR80","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","volume":"41","author":"NT Wetherall","year":"2003","unstructured":"Wetherall, N. T. et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J. Clin. Microbiol. 41, 742\u2013750 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"39738_CR81","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1743-422X-5-109","volume":"5","author":"MC Eichelberger","year":"2008","unstructured":"Eichelberger, M. C., Hassantoufighi, A., Wu, M. & Li, M. Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay. Virol. J. 5, 109 (2008).","journal-title":"Virol. J."},{"key":"39738_CR82","doi-asserted-by":"crossref","unstructured":"Van Hoecke, L., Job, E.R., Saelens, X. & Roose, K. Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J. Vis. Exp. 123, e55398 (2017).","DOI":"10.3791\/55398"},{"key":"39738_CR83","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1073\/pnas.1319051111","volume":"111","author":"SH Chang","year":"2014","unstructured":"Chang, S. H. et al. T helper 17 cells play a critical pathogenic role in lung cancer. Proc. Natl Acad. Sci. USA 111, 5664\u20135669 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39738_CR84","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","volume":"20","author":"T Stuart","year":"2019","unstructured":"Stuart, T. & Satija, R. Integrative single-cell analysis. Nat. Rev. Genet. 20, 257\u2013272 (2019).","journal-title":"Nat. Rev. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39738-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39738-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39738-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T20:02:37Z","timestamp":1688500957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39738-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39738"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-39738-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.T., M.S.N, Y.H., and D.D.H. are listed as co-inventors on a provisional patent application filed by Columbia University for the treatment for COVID-19 and other viral respiratory infections using 7DW8-5 described in this manuscript. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3959"}}